Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: Using Enhanced External Counterpulsation to Recover Cardiovascular Function for Patient of Chronic Diseases [NA]

View source ↗

Summary

A completed clinical trial evaluating enhanced external counterpulsation for recovering cardiovascular function in patients with Long COVID symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enhanced External Counterpulsation (EECP)

Snippet

Sponsor: National Defense Medical Center, Taiwan | Conditions: Long COVID Symptoms | NA | Status: COMPLETED